Barclays Preview of AFLAC's (AFL) Investor Day: Attractive Valuation as EPS Growth to Rebound
Tweet
Share
E-mailGet Alerts AFL Hot Sheet
Price: $121.45 +0.29%
Rating Summary:
5 Buy, 16 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 16 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Barclays maintains an 'Overweight' on AFLAC (NYSE: AFL) price target of $58.00.
Analyst, Jay Gelb, said, "We view AFL as one of the strongest franchises in the Life Insurance industry with the highest ROE yet it currently has a P/E of 6.2x our 2013 EPS estimate, which is below the sector P/E. We expect AFL's EPS growth to rebound in 2013 driven by consistent earnings growth in Japan and the U.S. with a modest benefit from share buybacks. AFL is nearly finished with de-risking its investment portfolio, which should remove a negative overhang."
Barclays sees FY13 EPS if $6.90 ($6.97 ex-FX effects) and sees 2013 new sales growth decline by 8% in Japan, but increase 5% in the U.S.
For an analyst ratings summary and ratings history on AFLAC click here. For more ratings news on AFLAC click here.
Shares of AFLAC closed at $43.09 yesterday.
Analyst, Jay Gelb, said, "We view AFL as one of the strongest franchises in the Life Insurance industry with the highest ROE yet it currently has a P/E of 6.2x our 2013 EPS estimate, which is below the sector P/E. We expect AFL's EPS growth to rebound in 2013 driven by consistent earnings growth in Japan and the U.S. with a modest benefit from share buybacks. AFL is nearly finished with de-risking its investment portfolio, which should remove a negative overhang."
Barclays sees FY13 EPS if $6.90 ($6.97 ex-FX effects) and sees 2013 new sales growth decline by 8% in Japan, but increase 5% in the U.S.
For an analyst ratings summary and ratings history on AFLAC click here. For more ratings news on AFLAC click here.
Shares of AFLAC closed at $43.09 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Barclays, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
